Association of cerebrovascular dysfunction with the development of Alzheimer’s disease-like pathology in OXYS rats

[1]  Grant R. Gordon,et al.  Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline , 2017, Experimental Gerontology.

[2]  C. Ayata,et al.  Emerging concepts in sporadic cerebral amyloid angiopathy. , 2017, Brain : a journal of neurology.

[3]  A. Kakita,et al.  PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease , 2017, Neuroscience Letters.

[4]  N. Stefanova,et al.  Impact of changes in neurotrophic supplementation on development of Alzheimer’s disease-like pathology in OXYS rats , 2017, Biochemistry (Moscow).

[5]  Junyang Jung,et al.  Nitric Oxide: Exploring the Contextual Link with Alzheimer's Disease , 2016, Oxidative medicine and cellular longevity.

[6]  J. Leszek,et al.  Inflammatory Response in the CNS: Friend or Foe? , 2016, Molecular Neurobiology.

[7]  N. Stefanova,et al.  An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology , 2016, Aging.

[8]  J. Camden,et al.  Purinergic receptors as potential therapeutic targets in Alzheimer's disease , 2016, Neuropharmacology.

[9]  O. Lazarov,et al.  Hippocampal neurogenesis: Learning to remember , 2016, Progress in Neurobiology.

[10]  L. Hannibal.  Nitric Oxide Homeostasis in Neurodegenerative Diseases. , 2016, Current Alzheimer research.

[11]  C. Mathiesen,et al.  GABAA Receptor-Mediated Bidirectional Control of Synaptic Activity, Intracellular Ca2+, Cerebral Blood Flow, and Oxygen Consumption in Mouse Somatosensory Cortex In Vivo. , 2015, Cerebral cortex.

[12]  N. Stefanova,et al.  Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of Alzheimer's disease‐like pathology , 2015, Journal of pineal research.

[13]  J. Schneider,et al.  Vascular contributions to cognitive impairment and dementia including Alzheimer's disease , 2015, Alzheimer's & Dementia.

[14]  Timothy J. Hohman,et al.  The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease. , 2015, JAMA neurology.

[15]  J. Calixto,et al.  B2 receptor blockage prevents Aβ-induced cognitive impairment by neuroinflammation inhibition , 2015, Behavioural Brain Research.

[16]  G. Weisman,et al.  P2Y receptors in Alzheimer's disease , 2015, Biology of the cell.

[17]  N. Stefanova,et al.  Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats , 2014, Oncotarget.

[18]  N. Blaes,et al.  Kinin receptors in vascular biology and pathology. , 2014, Current vascular pharmacology.

[19]  O. Kozhevnikova,et al.  Senescence-accelerated OXYS rats: A model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease , 2014, Cell cycle.

[20]  O. Forlenza,et al.  Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study , 2014, Journal of Neural Transmission.

[21]  V. Skulachev,et al.  Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1. , 2013, Journal of Alzheimer's disease : JAD.

[22]  K. Fox,et al.  The role of nitric oxide in pre-synaptic plasticity and homeostasis , 2013, Front. Cell. Neurosci..

[23]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[24]  B. Zlokovic,et al.  Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[25]  V. Stonik,et al.  Comparative Study on Hypertension-Induced Cerebral Vascular Alterations in Two Rat Lines by Magnetic Resonance Angiography , 2012 .

[26]  F. Mackenzie,et al.  Diverse roles for VEGF-A in the nervous system , 2012, Development.

[27]  B. Zlokovic.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[28]  N. Hattori,et al.  Analysis of PLA2G6 in patients with frontotemporal type of dementia. , 2011, Parkinsonism & related disorders.

[29]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[30]  N. Stefanova,et al.  Behavioral effects induced by mitochondria-targeted antioxidant SkQ1 in Wistar and senescence-accelerated OXYS rats. , 2010, Journal of Alzheimer's disease : JAD.

[31]  Jack C. de la Torre,et al.  Vascular risk factor detection and control may prevent Alzheimer's disease , 2010, Ageing Research Reviews.

[32]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[33]  N. Toda,et al.  Cerebral blood flow regulation by nitric oxide in neurological disorders. , 2009, Canadian journal of physiology and pharmacology.

[34]  M. Mattson,et al.  Amyloid-β Induces a Caspase-mediated Cleavage of P2X4 to Promote Purinotoxicity , 2009, NeuroMolecular Medicine.

[35]  E. Zenteno,et al.  Amyloid-β25–35 impairs memory and increases NO in the temporal cortex of rats , 2009, Neuroscience Research.

[36]  Der-Zen Liu,et al.  Hemorheological Mechanisms in Alzheimer's Disease , 2007, Microcirculation.

[37]  V. Stonik,et al.  Effect of histochrome on brain vessels and research and exploratory activity of senescence-accelerated OXYS rats , 2007, Bulletin of Experimental Biology and Medicine.

[38]  O. Forlenza,et al.  Platelet phospholipase A2 activity in Alzheimer’s disease and mild cognitive impairment , 2004, Journal of Neural Transmission.

[39]  Yong Song Gho,et al.  Co-accumulation of vascular endothelial growth factor with β-amyloid in the brain of patients with Alzheimer’s disease , 2004, Neurobiology of Aging.

[40]  R. Schliebs,et al.  Fibrillary beta-amyloid deposits are closely associated with atrophic nitric oxide synthase (NOS)-expressing neurons but do not upregulate the inducible NOS in transgenic Tg2576 mouse brain with Alzheimer pathology , 2001, Neuroscience Letters.

[41]  H. Gertz,et al.  Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a , 2000, Brain Research.

[42]  P. Emson,et al.  Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains. , 1996, Brain research. Molecular brain research.

[43]  S. Tarantini,et al.  Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. , 2017, American journal of physiology. Heart and circulatory physiology.

[44]  O. Forlenza,et al.  Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment. , 2004, Journal of neural transmission.

[45]  A. Scheibel,et al.  Alzheimer's disease as a capillary dementia. , 1989, Annals of medicine.